SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-071931
Filing Date
2022-11-14
Accepted
2022-11-14 13:06:14
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_bioessence.htm   iXBRL 10-Q 584558
2 CERTIFICATION f10q0922ex31-1_bioessence.htm EX-31.1 10760
3 CERTIFICATION f10q0922ex31-2_bioessence.htm EX-31.2 10578
4 CERTIFICATION f10q0922ex32-1_bioessence.htm EX-32.1 4961
5 CERTIFICATION f10q0922ex32-2_bioessence.htm EX-32.2 5585
6 GRAPHIC image_001.jpg GRAPHIC 16220
  Complete submission text file 0001213900-22-071931.txt   4079247

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20220930.xsd EX-101.SCH 72758
8 XBRL CALCULATION FILE cik00001723059-20220930_cal.xml EX-101.CAL 32822
9 XBRL DEFINITION FILE cik00001723059-20220930_def.xml EX-101.DEF 216087
10 XBRL LABEL FILE cik00001723059-20220930_lab.xml EX-101.LAB 470980
11 XBRL PRESENTATION FILE cik00001723059-20220930_pre.xml EX-101.PRE 223920
66 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_bioessence_htm.xml XML 422884
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 221383111
SIC: 2834 Pharmaceutical Preparations